68 research outputs found
Digital sculpting for historical representation: Neville tomb case study
Despite digital 3-D polygon modelling applications providing a common and powerful tool-set for archaeological, architectural and historical visualisation over recent years, the relatively recent developments in high-resolution sculpting software allow for the possibility to create digital outcomes with a degree of surface fidelity not previously obtainable from the more widely used poly-modelling software packages. Such digital sculpting applications are more commonly applied within the video games and TV/motion picture industries, the intention of this paper is to show how such tools and methodologies together with existing scanned data and some historical knowledge can remediate and re-imagine lost sculptural form. The intended research will focus on an examination and partial re-construction of the tomb of Sir John Neville, 3rd Baron Raby located at Durham Cathedral, County Durham UK
CD74 in kidney disease
CD74 (invariant MHC class II) regulates protein trafficking and is a receptor for macrophage
migration inhibitory factor (MIF) and d-dopachrome tautomerase (d-DT/MIF-2).
CD74 expression is increased in tubular cells and/or glomerular podocytes and parietal
cells in human metabolic nephropathies, polycystic kidney disease, graft rejection
and kidney cancer and in experimental diabetic nephropathy and glomerulonephritis.
Stressors like abnormal metabolite (glucose, lyso-Gb3) levels and inflammatory cytokines
increase kidney cell CD74. MIF activates CD74 to increase inflammatory cytokines
in podocytes and tubular cells and proliferation in glomerular parietal epithelial cells and
cyst cells. MIF overexpression promotes while MIF targeting protects from experimental
glomerular injury and kidney cysts, and interference with MIF/CD74 signaling or CD74
deficiency protected from crescentic glomerulonephritis. However, CD74 may protect
from interstitial kidney fibrosis. Furthermore, CD74 expression by stressed kidney cells
raises questions about the kidney safety of cancer therapy strategies delivering lethal
immunoconjugates to CD74-expressing cells. Thus, understanding CD74 biology in
kidney cells is relevant for kidney therapeuticsGrant support: ISCIII and FEDER funds CP14/00133, PI13/00047, Sociedad Española de Nefrologia, ISCIII-RETIC REDinREN/RD012/0021, Comunidad de Madrid CIFRA S2010/
BMD-2378. Salary support: FIS to LV-R, Miguel Servet to MS-N. Programa Intensificación Actividad Investigadora (ISCIII/
Agencia Laín-Entralgo/CM) to AO
Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is a malignant disease of the white blood cells. The etiology of ALL is believed to be multifactorial and likely to involve an interplay of environmental and genetic variables. We performed a genome-wide association study of 355 750 single-nucleotide polymorphisms (SNPs) in 474 controls and 419 childhood ALL cases characterized by a t(12;21)(p13;q22) — the most common chromosomal translocation observed in childhood ALL — which leads to an ETV6–RUNX1 gene fusion. The eight most strongly associated SNPs were followed-up in 951 ETV6-RUNX1-positive cases and 3061 controls from Germany/Austria and Italy, respectively. We identified a novel, genome-wide significant risk locus at 3q28 (TP63, rs17505102, PCMH=8.94 × 10−9, OR=0.65). The separate analysis of the combined German/Austrian sample only, revealed additional genome-wide significant associations at 11q11 (OR8U8, rs1945213, P=9.14 × 10−11, OR=0.69) and 8p21.3 (near INTS10, rs920590, P=6.12 × 10−9, OR=1.36). These associations and another association at 11p11.2 (PTPRJ, rs3942852, P=4.95 × 10−7, OR=0.72) remained significant in the German/Austrian replication panel after correction for multiple testing. Our findings demonstrate that germline genetic variation can specifically contribute to the risk of ETV6–RUNX1-positive childhood ALL. The identification of TP63 and PTPRJ as susceptibility genes emphasize the role of the TP53 gene family and the importance of proteins regulating cellular processes in connection with tumorigenesis
Post-translational regulation of macrophage migration inhibitory factor: Basis for functional fine-tuning
Macrophage migration inhibitory factor (MIF) is a chemokine-like protein and an important mediator in the inflammatory response. Unlike most other pro-inflammatory cytokines, a number of cell types constitutively express MIF and secretion occurs from preformed stores. MIF is an evolutionarily conserved protein that shows a remarkable functional diversity, including specific binding to surface CD74 and chemokine receptors and the presence of two intrinsic tautomerase and oxidoreductase activities. Several studies have shown that MIF is subject to post-translational modification, particularly redox-dependent modification of the catalytic proline and cysteine residues. In this review, we summarize and discuss MIF post-translational modifications and their effects on the biological properties of this protein. We propose that the redox-sensitive residues in MIF will be modified at sites of inflammation and that this will add further depth to the functional diversity of this intriguing cytokine
5.18 Milatuzumab as a Single Agent in Refractory Chronic Lymphocytic Leukemia: Interim Results of a Phase 1–2 Study and Future Plans
evaluation of multiplex real time pcr for identifying dermatophytes in clinical samples- a multicenter study
A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach
- …
